NCT04320121View on ClinicalTrials.gov

Effect of Nelutri™ on Musculoskeletal Biomarkers in Relative Sarcopenia Adults

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

December 30, 2020

Study Completion Date

December 31, 2020

Conditions
Muscular Sarcoidosis
Interventions
DIETARY_SUPPLEMENT

Nelutri™

Nelutri™ 2,000 mg/day for 12 weeks

DIETARY_SUPPLEMENT

Placebo group

Placebo 2,000 mg/day for 12 weeks

Trial Locations (1)

50612

Pusan National University Yangsan Hospital, Yangsan

All Listed Sponsors
lead

Pusan National University Yangsan Hospital

OTHER

NCT04320121 - Effect of Nelutri™ on Musculoskeletal Biomarkers in Relative Sarcopenia Adults | Biotech Hunter | Biotech Hunter